Conexeu Sciences (NASDAQ:CNXU) Shares Down 5.2% – Here’s What Happened

Conexeu Sciences Inc. (NASDAQ:CNXU) traded down 5.2% during trading on Thursday. The company traded as low as $3.30 and last traded at $3.45. 243,517 shares changed hands during mid-day trading, an increase of 24% from the average session volume of 197,147 shares. The stock had previously closed at $3.64.

Wall Street Analyst Weigh In

CNXU has been the topic of several research reports. Weiss Ratings initiated coverage on shares of Conexeu Sciences in a research note on Monday, August 17th. They issued a “sell (e-)” rating on the stock. HC Wainwright began coverage on shares of Conexeu Sciences in a report on Monday, June 22nd. They issued a “buy” rating and a $20.00 price objective for the company. Finally, Zacks Research upgraded shares of Conexeu Sciences to a “hold” rating in a research report on Monday, June 29th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Conexeu Sciences presently has a consensus rating of “Hold” and an average price target of $20.00.

Conexeu Sciences Price Performance

The stock has a market capitalization of $109.74 million and a PE ratio of -9.72. The company’s 50 day moving average price is $5.94.

Conexeu Sciences (NASDAQ:CNXU) last issued its quarterly earnings results on Monday, September 14th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). As a group, equities analysts expect that Conexeu Sciences Inc. will post -0.40 earnings per share for the current year.

About Conexeu Sciences

Conexeu is a company focused on building a new class of collagen-based regenerative tissue products. The Company was incorporated on November 2, 2022 under the Business Corporations Act (British Columbia) and was continued out of British Columbia and domesticated into the State of Nevada under the laws of the State of Nevada on April 10, 2025. — Conexeu is an early-stage medical device company formed to acquire and commercialize intellectual property (“IP”) developed over more than a decade at the University of British Columbia (the “University”) and the BC Professional Firefighters Burn and Wound Healing Laboratory.